Topics
midePlace
myelomaDisease
dexamethasoneChemical substance
thalidomideChemical substance
prednisoneChemical substance
mide have recently changed the treat-ment paradigm of myeloma. In young, newly diagnosed patients, the combina-tion of thalidomide and dexamethasone has been widely used as induction treat-ment before autologous stem cell trans-plantation (ASCT). In 2 randomized stud-ies, consolidation or maintenance with low-dose thalidomide has extended both progression-free and overall survival in patients who underwent ASCT at diagno-sis. In elderly, newly diagnosed patients, 3 independent randomized studies have reported that the oral combination of mel-phalan and prednisone plus thalidomid
After decades of disuse because of its teratogenic effects, thalidomide has had a resurgence of use ...
Despite the good response of stem cell transplant (SCT) in the treatment of multiple myeloma (MM), m...
Multiple myeloma management has undergone profound changes in the past thanks to advances in our und...
Thalidomide, bortezomib and lenalidomide have recently changed the treatment paradigm of myeloma. In...
In the past decade, one of the major ad-vances in the management of patients with symptomatic newly ...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
Copyright © 2014 Z. Al-Mansour and M. Ramanathan. This is an open access article distributed under t...
textabstractMultiple myeloma management has undergone profound changes in the past thanks to advance...
Thalidomide, bortezomib, and lenalidomide have recently changed the treatment paradigm of myeloma. I...
Maintaining results of successful induction therapy is an important goal in multiple myeloma. Here, ...
none28siMaintaining results of successful induction therapy is an important goal in multiple myeloma...
Multiple myeloma management has undergone profound changes in the past thanks to advances in our und...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
International audienceFrom April 2003 to December 2006, 195 patients with de novo symptomatic myelom...
After decades of disuse because of its teratogenic effects, thalidomide has had a resurgence of use ...
Despite the good response of stem cell transplant (SCT) in the treatment of multiple myeloma (MM), m...
Multiple myeloma management has undergone profound changes in the past thanks to advances in our und...
Thalidomide, bortezomib and lenalidomide have recently changed the treatment paradigm of myeloma. In...
In the past decade, one of the major ad-vances in the management of patients with symptomatic newly ...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
Copyright © 2014 Z. Al-Mansour and M. Ramanathan. This is an open access article distributed under t...
textabstractMultiple myeloma management has undergone profound changes in the past thanks to advance...
Thalidomide, bortezomib, and lenalidomide have recently changed the treatment paradigm of myeloma. I...
Maintaining results of successful induction therapy is an important goal in multiple myeloma. Here, ...
none28siMaintaining results of successful induction therapy is an important goal in multiple myeloma...
Multiple myeloma management has undergone profound changes in the past thanks to advances in our und...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
International audienceFrom April 2003 to December 2006, 195 patients with de novo symptomatic myelom...
After decades of disuse because of its teratogenic effects, thalidomide has had a resurgence of use ...
Despite the good response of stem cell transplant (SCT) in the treatment of multiple myeloma (MM), m...
Multiple myeloma management has undergone profound changes in the past thanks to advances in our und...
Add to ORKG